dc.contributor
Institut Català de la Salut
dc.contributor
[Shteinberg M] Pulmonology Institute and CF Center, Carmel Medical Center and the Technion, Israel Institute of Technology, Haifa, Israel. [Boyd J] European Lung Foundation, Sheffield, UK. [Aliberti S] Dept of Pathophysiology and Transplantation, University of Milan, and Internal Medicine Dept, Respiratory Unit and Cystic Fibrosis Adult Center, Milan, Italy. [Polverino E] Servei de Pneumologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Thorax Institute, Institute of Biomedical Research August Pi i Sunyer, University of Barcelona, Barcelona, Spain. [Harris B, Berg T] European Lung Foundation Bronchiectasis Patient Advisory Group, Edinburgh, UK
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Shteinberg, Michal
dc.contributor.author
Boyd, Jeanette
dc.contributor.author
Harris, Bridget
dc.contributor.author
Berg, Tove
dc.contributor.author
Polverino, Eva
dc.contributor.author
Aliberti, Stefano
dc.date.accessioned
2025-10-24T10:19:28Z
dc.date.available
2025-10-24T10:19:28Z
dc.date.issued
2022-03-14T13:22:51Z
dc.date.issued
2022-03-14T13:22:51Z
dc.date.issued
2021-02-15
dc.identifier
Shteinberg M, Boyd J, Aliberti S, Polverino E, Harris B, Berg T, et al. What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey. ERJ Open Res. 2021 Feb 15;7:00807–2020.
dc.identifier
https://hdl.handle.net/11351/7167
dc.identifier
10.1183/23120541.00807-2020
dc.identifier
000625441800065
dc.identifier.uri
https://hdl.handle.net/11351/7167
dc.description.abstract
Experiencias de los pacientes; Enfermedad pulmonar
dc.description.abstract
Experiències dels pacients; Malaltia pulmonar
dc.description.abstract
Patient experiences; Lung disease
dc.description.abstract
Patients' experiences of NTM pulmonary disease highlight important and unmet needs for better pharmacological treatment and education of medical staff
dc.description.abstract
European Respiratory Society (EMBARC Clinical Research Collaboration)
dc.format
application/pdf
dc.publisher
European Respiratory Society
dc.relation
ERJ Open Research;7
dc.relation
https://doi.org/1183/23120541.00807-2020
dc.rights
Attribution-NonCommercial 4.0 International
dc.rights
http://creativecommons.org/licenses/by-nc/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Micobacteriosis - Tractament
dc.subject
Pacients - Satisfacció
dc.subject
DISEASES::Bacterial Infections and Mycoses::Bacterial Infections::Gram-Positive Bacterial Infections::Actinomycetales Infections::Mycobacterium Infections::Mycobacterium Infections, Nontuberculous
dc.subject
Other subheadings::Other subheadings::/therapy
dc.subject
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Data Collection::Surveys and Questionnaires
dc.subject
ENFERMEDADES::infecciones bacterianas y micosis::infecciones bacterianas::infecciones por bacterias grampositivas::infecciones por Actinomycetales::micobacteriosis::infecciones por micobacterias no tuberculosas
dc.subject
Otros calificadores::Otros calificadores::/terapia
dc.subject
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::recopilación de datos::encuestas y cuestionarios
dc.title
What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
